18 March 2020
In the current financial climate, with National Health Services across Western countries under increasing pressure to ‘do more with less’, biosimilar drugs are starting to attract significant attention and are likely to reshape the pharmaceutical industry as we know it.
11 March 2020
Industry Executives - Q&A
Recently Dan Nathan, Managing Partner at Euromedica, spoke with Olivier Charmeil, Executive Committee member and EVP, General Medicines at Sanofi, as he moves into a new internal position and to share his insights on leadership within a transformational industry.
6 March 2020
Celebrating International Women's Day
Euromedica reviews the progress of gender diversity across the consumer and life sciences sectors and celebrates the success of some of our clients.
10 February 2020
The Fourth Industrial Revolution (4IR): Is time running out for some?
4IR innovations are expected to contribute up to $3.7 trillion in value by 2025 - so how can organisations become competitive?
Get in touch to learn how we can add value to your business or career.